Dimensional Fund Advisors LP Blueprint Medicines Corp Transaction History

Dimensional Fund Advisors LP

$391 Billion
Q1 2025

A detailed history of Dimensional Fund Advisors LP transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 18,604 shares of BPMC stock, worth $2.38 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,604

Previous 40,208 53.73%

Holding current value

$2.38 Million

Previous $3.51 Million 53.05%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$86.69 - $115.63 $1.87 Million - $2.5 Million	-21,604 Reduced 53.73%	18,604 $1.65 Million
Q4 2024 Feb 13, 2025	BUY	$82.48 - $101.39 $98,976 - $121,668	1,200 Added 3.08%	40,208 $3.51 Million
Q3 2024 Nov 07, 2024	BUY	$84.1 - $120.5 $591,138 - $846,994	7,029 Added 21.98%	39,008 $3.61 Million
Q2 2024 Aug 09, 2024	SELL	$85.18 - $108.78 $1.42 Million - $1.81 Million	-16,619 Reduced 34.2%	31,979 $3.45 Million
Q1 2024 May 10, 2024	SELL	$73.17 - $99.79 $2.3 Million - $3.13 Million	-31,381 Reduced 39.24%	48,598 $4.61 Million
Q4 2023 Feb 07, 2024	SELL	$43.96 - $92.84 $4.03 Million - $8.51 Million	-91,684 Reduced 53.41%	79,979 $7.38 Million
Q3 2023 Nov 09, 2023	SELL	$46.9 - $66.0 $5.27 Million - $7.41 Million	-112,307 Reduced 39.55%	171,663 $8.62 Million
Q2 2023 Aug 09, 2023	SELL	$42.2 - $66.37 $1.02 Million - $1.6 Million	-24,131 Reduced 7.83%	283,970 $17.9 Million
Q1 2023 May 12, 2023	SELL	$37.97 - $50.0 $1.88 Million - $2.48 Million	-49,630 Reduced 13.87%	308,101 $13.9 Million
Q4 2022 Feb 09, 2023	SELL	$41.06 - $66.48 $3.15 Million - $5.1 Million	-76,725 Reduced 17.66%	357,731 $15.7 Million
Q3 2022 Nov 10, 2022	SELL	$49.93 - $77.7 $4.98 Million - $7.74 Million	-99,654 Reduced 18.66%	434,456 $28.6 Million
Q2 2022 Aug 12, 2022	SELL	$45.23 - $70.15 $921,335 - $1.43 Million	-20,370 Reduced 3.67%	534,110 $27 Million
Q1 2022 May 13, 2022	BUY	$54.1 - $110.08 $5.28 Million - $10.7 Million	97,557 Added 21.35%	554,480 $35.4 Million
Q4 2021 Feb 09, 2022	BUY	$94.25 - $115.99 $16.6 Million - $20.4 Million	175,896 Added 62.59%	456,923 $48.9 Million
Q3 2021 Nov 12, 2021	BUY	$80.98 - $109.47 $17.6 Million - $23.7 Million	216,778 Added 337.4%	281,027 $28.9 Million
Q2 2021 Aug 12, 2021	BUY	$82.78 - $101.0 $259,266 - $316,332	3,132 Added 5.12%	64,249 $5.65 Million
Q1 2021 May 14, 2021	SELL	$90.71 - $108.28 $521,128 - $622,068	-5,745 Reduced 8.59%	61,117 $5.95 Million
Q4 2020 Feb 25, 2021	BUY	$92.08 - $124.48 $6.16 Million - $8.32 Million	66,862 New	66,862 $7.5 Million

Others Institutions Holding BPMC

# of Institutions

391

Shares Held

68.5M

Call Options Held

1.54M

Put Options Held

1.08M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $7.64B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Blueprint Medicines Corp Transaction History